Ameloblastoma: Clinical Trials

2 trials for Ameloblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Unknown 1
Phase 21Not yet recruiting 1

Follow Ameloblastoma: new trials by email Literature Review of Ameloblastoma trials Research Report on Ameloblastoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma
Dabrafenib and trametinib (combination) - Ameloblastoma
Phase 2 / Phase 3Not yet recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University462025-03-012025-02-11
Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma
Dabrafenib - Ameloblastoma
Phase 3UnknownShandong University102024-03-012024-02-20

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Odontogenic Tumors (2)

Interventions

dabrafenib (2)  ·  trametinib (1)

Sponsors

Shandong University (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)

Top investigators

Qing Li (1)

Results publications

PMID 37966914, PMID 39274556